Report Overview

The global human rotavirus vaccine market is US$ xx billion in 2019 and expected to reach US$ xx billion by 2028, and the market is projected to grow at a CAGR of ~ 11.2 % during the forecast period 2019-2028

In the developing countries, the vaccine prevents 15-34% of severe diarrhea and in the developed countries, the vaccine prevents 37-96% of severe diarrhea. The vaccine decreases the risk of death that is caused due to diarrhea among young children. WHO recommended that rotavirus vaccines should be included in national routine vaccination programs, particularly in the countries, with high versatility to the disease. This can be done while promoting breastfeeding, hand washing, clean water, and good sanitation.

According to the data of May 2016,81 countries have introduced Rotarix and RotaTeq vaccines in their national immunization program. After the introduction of rotavirus vaccine, there was a swift decline in the severe rotavirus cases in many countries. Estimates have shown that there is a huge reduction in all-cause diarrhea hospitalizations in high-income countries which ranges from 20 to 50%, in middle-income countries from 17-55% and reduction in rotavirus cases ranging from 49 to 92% in high-income countries, 54 to 59% in middle-income countries and 69 to 81% in low-income countries. These estimates show that there would be a significant growth in the rotavirus vaccines market during the forecast period.



Market Drivers

Increase in Incidents of Rotavirus Infection

Rotavirus disease is highly transmitted disease and spreads very easily among children owing to their poor hygiene. The rotavirus vaccine is a common problem in clinics and hospitals. As of 2013, 215,000 deaths were recorded due to rotavirus. Considering the estimates, this increase in incidents is expected to drive the rotavirus vaccine market during the forecast period.

Support from Organizations

Various organizations such as UNICEF and GAVI have supported the adoption of rotavirus vaccine in various countries owing to large scale vaccination and accessing the vaccines at lower prices to reduce the cases of infection and leading to a healthy lifestyle. This factor is anticipated to drive the growth of the market.